tradingkey.logo
搜尋

Prelude Therapeutics Inc

PRLD
添加自選
4.600USD
-0.450-8.91%
收盤 07-31 16:00美東報價延遲15分鐘
366.37M總市值
虧損本益比TTM

PRLD 財務數據

透過專為投資者打造的一站式數據看板,全面查看 Prelude Therapeutics Inc 的財務狀況。平台將複雜的財務報表整理為可自定義的視圖,助您更輕鬆地進行財務分析。您可以查看最新年度財務報告,也可以通過利潤表、資產負債表和現金流量表,按季度分析公司表現。借助實時財務指標,持續追蹤公司的經營狀況和市場表現更加便捷。

Prelude Therapeutics Inc財報日曆

最新發布
5月 12, 2026
每股收益 / 預測值
-0.13/-0.25
營業收入 / 預測值
4.58M/0.00
報告期
FY2025 財報
營業收入(YoY)
12.14M
73.43%
每股收益(YoY)
-1.29
22.93%
分析師評級
BUY
2026/08/02
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
財務指標
每股收益
70.20%-0.13
45.48%-0.21
39.10%-0.26
10.37%-0.41
-1.74%-0.42
20.32%-0.38
5.99%-0.43
15.26%-0.46
28.53%-0.42
20.86%-0.48
---0.45
---0.54
---0.58
---0.60
---1.84
----
----
----
----
----
營業收入
--4.58M
41.00%5.64M
116.67%6.50M
----
----
--4.00M
--3.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
淨利潤
67.63%-10.38M
42.72%-16.46M
38.88%-19.73M
10.10%-31.23M
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
利潤率
---226.75%
59.38%-291.79%
71.79%-303.46%
----
----
---718.27%
---1075.70%
----
----
----
----
----
----
----
----
----
----
----
----
----
毛利率
--100.00%
0.00%100.00%
0.00%100.00%
----
----
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
資產負債率
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
--0.04%
--0.12%
--0.18%
--0.23%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
營業收入
--4.58M
41.00%5.64M
116.67%6.50M
----
----
--4.00M
--3.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
營業利潤
59.03%-14.18M
48.72%-17.35M
40.60%-20.42M
13.37%-32.19M
-0.77%-34.61M
9.49%-33.83M
-2.97%-34.38M
-14.71%-37.16M
-17.96%-34.34M
-11.96%-37.38M
-9.80%-33.38M
-9.97%-32.40M
3.87%-29.11M
-1.14%-33.38M
1.39%-30.41M
-5.51%-29.46M
-37.88%-30.29M
-69.75%-33.01M
-69.95%-30.84M
---27.92M
淨利潤
67.63%-10.38M
42.72%-16.46M
38.88%-19.73M
10.10%-31.23M
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
流動資產
-17.39%84.59M
-22.23%105.69M
-62.70%58.33M
-57.93%76.88M
-50.14%102.40M
-42.32%135.90M
-33.43%156.39M
-29.78%182.71M
17.18%205.37M
15.27%235.59M
3.54%234.92M
4.66%260.21M
-35.08%175.26M
-30.75%204.38M
-30.38%226.89M
-27.85%248.62M
-26.04%269.97M
33.65%295.12M
36.90%325.90M
1022.50%344.57M
流動負債總額
110.85%41.72M
106.68%52.99M
-18.15%18.19M
-10.40%20.91M
12.15%19.79M
17.46%25.64M
31.56%22.22M
53.62%23.34M
-10.27%17.64M
0.59%21.83M
-21.65%16.89M
-3.93%15.19M
22.36%19.66M
13.03%21.70M
9.65%21.56M
7.73%15.81M
29.34%16.07M
68.80%19.20M
73.11%19.66M
160.28%14.68M
總資產
-15.30%119.64M
-19.49%141.31M
-51.95%94.75M
-48.76%114.92M
-42.83%141.26M
-36.79%175.51M
-23.71%197.22M
-20.07%224.29M
24.60%247.11M
25.93%277.67M
6.68%258.51M
8.32%280.61M
-29.34%198.32M
-27.73%220.50M
-26.84%242.33M
-25.90%259.06M
-24.11%280.67M
36.45%305.10M
38.19%331.22M
967.52%349.58M
總負債
56.13%59.46M
64.97%72.68M
-11.20%36.22M
-6.99%39.08M
4.70%38.08M
8.58%44.06M
101.39%40.79M
126.48%42.02M
57.98%36.37M
61.89%40.58M
-18.72%20.25M
1.87%18.55M
22.08%23.02M
30.53%25.06M
24.76%24.92M
19.65%18.21M
42.18%18.86M
68.33%19.20M
75.62%19.98M
168.29%15.22M
總權益
-41.67%60.18M
-47.79%68.64M
-62.58%58.53M
-58.39%75.84M
-51.04%103.18M
-44.55%131.46M
-34.34%156.43M
-30.44%182.28M
20.22%210.73M
21.31%237.09M
9.59%238.26M
8.81%262.06M
-33.04%175.30M
-31.64%195.44M
-30.15%217.41M
-27.97%240.84M
-26.57%261.81M
34.74%285.90M
36.33%311.24M
1134.99%334.36M
經營淨額
36.65%-21.68M
211.45%23.12M
29.97%-19.11M
-13.09%-26.07M
-7.68%-34.23M
12.02%-20.74M
-6.28%-27.30M
16.67%-23.06M
-5.50%-31.79M
-2.84%-23.58M
-25.66%-25.68M
-49.82%-27.67M
-37.63%-30.13M
10.80%-22.93M
6.13%-20.44M
7.25%-18.47M
-35.63%-21.89M
-73.11%-25.70M
-74.09%-21.77M
---19.91M
投資淨額
-86.33%8.50M
-372.80%-60.34M
273.53%40.09M
-55.89%11.52M
99.18%62.19M
185.91%22.12M
-28.66%10.73M
134.63%26.12M
73.46%31.22M
470.92%7.74M
-30.37%15.04M
-539.01%-75.43M
-56.68%18.00M
175.11%1.35M
108.29%21.61M
4609.45%17.18M
4313.79%41.55M
-448.33%-1.80M
-153212.94%-260.63M
---381.00K
融資淨額
-96.25%-314.00K
73464.71%24.94M
96.18%-5.00K
-37.29%37.00K
-1042.86%-160.00K
-100.13%-34.00K
-248.86%-131.00K
-99.95%59.00K
94.80%-14.00K
16181.94%25.24M
-40.54%88.00K
30913.65%111.34M
-275.82%-269.00K
-92.07%155.00K
-79.18%148.00K
-14.93%359.00K
-99.91%153.00K
249.50%1.95M
-99.67%711.00K
--422.00K

常見問題

Prelude Therapeutics Inc的總收入是多少?

根據Prelude Therapeutics Inc的FY2025財報,總收入達到12.14M(同比變化7.00M)。

Prelude Therapeutics Inc的流動資產是多少?

根據Prelude Therapeutics Inc的FY2025財報,流動資產為105.69M(同比變化-22.23)。

Prelude Therapeutics Inc的總資產是多少?

根據Prelude Therapeutics Inc的FY2025財報,Prelude Therapeutics Inc的總資產為141.31M(同比變化-19.49)。

Prelude Therapeutics Inc的總負債是多少?

根據Prelude Therapeutics Inc的FY2025財報,Prelude Therapeutics Inc的總責任為72.68M(同比變化64.97)。

Prelude Therapeutics Inc的總權益是多少?

根據Prelude Therapeutics Inc的FY2025財報,Prelude Therapeutics Inc的總權益為68.64M(同比變化-47.79)。

Prelude Therapeutics Inc的淨營業收入是多少?

根據Prelude Therapeutics Inc的FY2025財報,Prelude Therapeutics Inc的淨營業收入為-104.57M(同比變化25.16)。

Prelude Therapeutics Inc的淨投資是多少?

根據Prelude Therapeutics Inc的FY2025財報,Prelude Therapeutics Inc的淨投資為53.46M(同比變化-40.73)。

Prelude Therapeutics Inc的淨融資是多少?

根據Prelude Therapeutics Inc的FY2025財報,Prelude Therapeutics Inc的淨融資為24.82M(同比變化20780.00)。

Prelude Therapeutics Inc的每股收益(EPS)是多少?

根據Prelude Therapeutics Inc的FY2025財報,每股收益(EPS)為-1.29(同比變化22.93)。

Prelude Therapeutics Inc的淨利潤是多少?

根據Prelude Therapeutics Inc的FY2025財報,淨利潤為-99.50M(同比變化21.76)。

Prelude Therapeutics Inc的淨利潤率是多少?

根據Prelude Therapeutics Inc的FY2025財報,淨利潤率為-819.59(同比變化54.89)。

Prelude Therapeutics Inc的股東權益回報率(ROE)是多少?

根據Prelude Therapeutics Inc的FY2025財報,股東權益回報率(ROE)為-99.45(同比變化-44.10)。

Prelude Therapeutics Inc的資產回報率(ROA)是多少?

根據Prelude Therapeutics Inc的FY2025財報,資產回報率(ROA)為-62.81(同比變化-11.91)。

Prelude Therapeutics Inc的營業利潤是多少?

根據Prelude Therapeutics Inc的FY2025財報,營業利潤為-104.57M(同比變化25.16)。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有